AIP
FDMT icon

Ameritas Investment Partners’s 4D Molecular Therapeutics FDMT Stock Holding History

Ameritas Investment Partners’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.3K Buy
4,159
+804
+24% +$7.83K ﹤0.01% 2205
2026
Q1 		$31.2K Hold
3,355
– – ﹤0.01% 2366
2025
Q4 		$25.2K Hold
3,355
– – ﹤0.01% 2519
2025
Q3 		$29.2K Sell
3,355
-1,527
-31% -$9.13K ﹤0.01% 2497
2025
Q2 		$18.1K Hold
4,882
– – ﹤0.01% 2705
2025
Q1 		$15.8K Hold
4,882
– – ﹤0.01% 2654
2024
Q4 		$27.2K Hold
4,882
– – ﹤0.01% 2499
2024
Q3 		$52.8K Hold
4,882
– – ﹤0.01% 2164
2024
Q2 		$102K Buy
4,882
+953
+24% +$23.9K ﹤0.01% 1706
2024
Q1 		$125K Hold
3,929
– – ﹤0.01% 1601
2023
Q4 		$79.6K Hold
3,929
– – ﹤0.01% 1890
2023
Q3 		$50K Buy
3,929
+1,321
+51% +$22.1K ﹤0.01% 2107
2023
Q2 		$47.1K Buy
2,608
+449
+21% +$8.27K ﹤0.01% 2089
2023
Q1 		$37.1K Hold
2,159
– – ﹤0.01% 2156
2022
Q4 		$42.8K Hold
2,159
– – ﹤0.01% 2165
2022
Q3 		$17K Hold
2,159
– – ﹤0.01% 2590
2022
Q2 		$15K Hold
2,159
– – ﹤0.01% 2682
2022
Q1 		$33K Hold
2,159
– – ﹤0.01% 2294
2021
Q4 		$47K Buy
2,159
+553
+34% +$13.6K ﹤0.01% 2163
2021
Q3 		$43K Buy
1,606
+973
+154% +$27.7K ﹤0.01% 2257
2021
Q2 		$15K Hold
633
– – ﹤0.01% 2850
2021
Q1 		$27K Buy
+633
New +$28K ﹤0.01% 2424

Other funds holding FDMT

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Ameritas Investment Partners's FDMT Position: Q2 2026 in Review

Ameritas Investment Partners increased its 4D Molecular Therapeutics (FDMT) stake by 24% in Q2 2026, buying an estimated $7.83K and bringing the position to 4,159 shares worth $55.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

Ameritas Investment Partners first reported a position in FDMT in Q1 2021 and has held it in 22 quarters since. The position peaked at $125K in Q1 2024. 158 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • Ameritas Investment Partners held 4,159 shares of 4D Molecular Therapeutics worth $55.3K as of Q2 2026.
  • Ameritas Investment Partners bought 804 4D Molecular Therapeutics shares in Q2 2026, an estimated $7.83K.
  • 4D Molecular Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2205 holding.
  • Ameritas Investment Partners first reported a position in 4D Molecular Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Ameritas Investment Partners's 4D Molecular Therapeutics position peaked at $125K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.